Pharmacologic profile of a low molecular weight heparin (enoxaparin): experimental and clinical validation of the prophylactic antithrombotic effects
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/1963021
其他信息:
PMID: 1963021
作者: J Fareed; J M Walenga; M Lassen; L Borris; D Hoppensteadt; ...
摘要: Some 10 low molecular weight heparin products are currently available for commercial use. Enoxaparin and fraxiparin appear to be the most developed low molecular weight heparins. Many well-designed clinical trials have been carried out for different clinical indications with both of these products. As shown in both experimental and clinical settings, the prophylactic antithrombotic efficacy of enoxaparin is distinct from other low molecular weight heparins. Enoxaparin has provided consistently i...
